Canntab Therapeutics Limited Share Price

Equities

CTABF

CA1377991023

Pharmaceuticals

Market Closed - OTC Markets 16:45:52 29/05/2024 BST 5-day change 1st Jan Change
0.0087 USD +19.18% Intraday chart for Canntab Therapeutics Limited -.--% -4.40%
1 month+19.18%
3 months+19.18%
Sales 2021 - Sales 2022 0.29 23.21 Capitalization 9.99M 790M
Net income 2021 -4M -316M Net income 2022 -3M -237M EV / Sales 2021 -
Net Debt 2021 75.05K 5.94M Net Debt 2022 1.15M 90.91M EV / Sales 2022 37,969,265 x
P/E ratio 2021
-7.9 x
P/E ratio 2022
-2.63 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 86.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day+19.18%
1 month+19.18%
3 months+19.18%
6 months-3.33%
Current year-4.40%
More quotes
1 month
0.01
Extreme 0.0075
0.01
Current year
0.00
Extreme 0.0016
0.01
1 year
0.00
Extreme 0.0016
0.01
3 years
0.00
Extreme 0.0016
0.71
5 years
0.00
Extreme 0.0016
0.89
10 years
0.00
Extreme 0.0016
1.64
More quotes
Date Price Change Volume
18/06/24 - +-NaN% 9

Delayed Quote OTC Markets, May 29, 2024 at 04:45 pm

More quotes
Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.
More about the company